☆ 4.5 Letter

A phase 1/2 study of chemosensitization with plerixafor plus G-CSF in relapsed or refractory acute myeloid leukemia

BLOOD CANCER JOURNAL (2017)

Get Full Text
Add to Collection

Journal

BLOOD CANCER JOURNAL
Volume 7, Issue -, Pages -

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/bcj.2017.21

Keywords

-

Categories

Oncology Hematology

Funding

  1. National Cancer Institute at the National Institutes of Health [P30 CA91842]
  2. Genzyme/Sanofi
  3. National Institutes of Health grant [K23 CA140707, R01 CA152329, R21 CA141523, R21 CA132269]

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.